Anixa Biosciences Inc Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Anixa Biosciences Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q2 2024.
  • Anixa Biosciences Inc Common Stock, Shares, Outstanding for the quarter ending July 31, 2024 was 32.1M shares, a 3.64% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 32.1M +1.13M +3.64% Jul 31, 2024 10-Q 2024-09-06
Q1 2024 32M +1.05M +3.38% Apr 30, 2024 10-Q 2024-06-04
Q4 2023 31.8M +832K +2.69% Jan 31, 2024 10-Q 2024-03-12
Q3 2023 31.1M +231K +0.75% Oct 31, 2023 10-Q 2024-09-06
Q2 2023 31M +364K +1.19% Jul 31, 2023 10-Q 2023-09-06
Q1 2023 31M +804K +2.67% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 30.9M +791K +2.62% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 30.9M +863K +2.87% Oct 31, 2022 10-K 2024-01-16
Q2 2022 30.7M +704K +2.35% Jul 31, 2022 10-Q 2022-09-09
Q1 2022 30.2M -1.3M -4.12% Apr 30, 2022 10-Q 2022-06-10
Q4 2021 30.1M +3.95M +15.1% Jan 31, 2022 10-Q 2022-03-11
Q3 2021 30.1M +5.8M +23.9% Oct 31, 2021 10-K 2023-01-04
Q2 2021 29.9M +6.3M +26.6% Jul 31, 2021 10-Q 2021-09-01
Q1 2021 31.4M +9.97M +46.4% Apr 30, 2021 10-Q 2021-06-10
Q4 2020 26.2M +5.34M +25.6% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 24.2M +3.92M +19.3% Oct 31, 2020 10-K 2022-01-04
Q2 2020 23.7M +3.49M +17.3% Jul 31, 2020 10-Q 2020-09-08
Q1 2020 21.5M +1.47M +7.37% Apr 30, 2020 10-Q 2020-06-09
Q4 2019 20.8M +1.37M +7.04% Jan 31, 2020 10-Q 2020-03-09
Q3 2019 20.3M +1.42M +7.53% Oct 31, 2019 10-K 2021-01-07
Q2 2019 20.2M +1.47M +7.85% Jul 31, 2019 10-Q 2019-09-06
Q1 2019 20M +3.15M +18.7% Apr 30, 2019 10-Q 2019-06-12
Q4 2018 19.5M +2.84M +17.1% Jan 31, 2019 10-Q 2019-03-13
Q3 2018 18.9M +2.31M +13.9% Oct 31, 2018 10-K 2020-01-09
Q2 2018 18.7M +3.58M +23.7% Jul 31, 2018 10-Q 2018-09-07
Q1 2018 16.9M +5.16M +44.1% Apr 30, 2018 10-Q 2018-06-11
Q4 2017 16.6M +7.87M +89.9% Jan 31, 2018 10-Q 2018-03-09
Q3 2017 16.6M +7.85M +89.7% Oct 31, 2017 10-K 2019-01-11
Q2 2017 15.1M +6.37M +72.8% Jul 31, 2017 10-Q 2017-09-08
Q1 2017 11.7M +2.96M +33.8% Apr 30, 2017 10-Q 2017-05-26
Q4 2016 8.76M +27.2K +0.31% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 8.75M +27.5K +0.32% Oct 31, 2016 10-K 2018-01-09
Q2 2016 8.75M +26.9K +0.31% Jul 31, 2016 10-Q 2016-08-19
Q1 2016 8.74M -210M -96% Apr 30, 2016 10-Q 2016-05-20
Q4 2015 8.73M -211M -96% Jan 31, 2016 10-Q 2016-02-19
Q3 2015 8.72M -63.3K -0.72% Oct 31, 2015 10-K/A 2016-12-08
Q2 2015 8.72M -228M -96.3% Jul 31, 2015 10-Q 2015-08-18
Q1 2015 219M -490K -0.22% Apr 30, 2015 10-Q 2015-05-22
Q4 2014 220M +9.19M +4.37% Jan 31, 2015 10-Q 2015-03-09
Q3 2014 8.79M -200M -95.8% Oct 31, 2014 10-K 2015-12-23
Q2 2014 237M +30.6M +14.9% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 219M +19.5M +9.77% Apr 30, 2014 10-Q 2014-06-16
Q4 2013 211M +25.4M +13.7% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 209M +24.3M +13.1% Oct 31, 2013 10-K 2015-01-29
Q2 2013 206M +30M +17.1% Jul 31, 2013 10-Q/A 2013-09-20
Q1 2013 200M +18.4M +10.2% Apr 30, 2013 10-Q/A 2013-06-19
Q4 2012 185M +4.65M +2.58% Jan 31, 2013 10-Q/A 2013-03-25
Q3 2012 185M +8.85M +5.02% Oct 31, 2012 10-K/A 2014-01-17
Q2 2012 176M +3.97M +2.31% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 181M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 180M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 176M +22.4M +14.6% Oct 31, 2011 10-K 2013-01-29
Q2 2011 172M Jul 31, 2011 10-Q/A 2011-10-14
Q3 2010 154M Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.